0.02 (7.273%)
ASX:Live
Short Term
Mean Reversion
Very Strong
Trend
Neutral
Event
Very Weak
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Valuation
Value
Consensus
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.3.9209.9688
Address
Unit 1 31 Sabre Drive Port Melbourne, Victoria (VIC) 3207
Description
Austco Healthcare Ltd. engages in the development, manufacture, and supply of hardware relating to healthcare and electronic communications systems. It operates through the following geographical segments: Australia/New Zealand, Asia, Europe, and North America. The company was founded by Robert Edward Grey in 2004 and is headquartered in Port Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.17 - 0.28
Trade Value (12mth)
AU$12,875.00
1 week
0%
1 month
12.24%
YTD
0%
1 year
37.81%
All time high
0.79
EPS 3 yr Growth
94.20%
EBITDA Margin
13.90%
Operating Cashflow
$11m
Free Cash Flow Return
32.10%
ROIC
20.00%
Interest Coverage
54.40
Quick Ratio
1.80
Shares on Issue (Fully Dilluted)
311m
HALO Sector
Industrials
Next Company Report Date
N/A
Ex Dividend Date (est.)
02-Mar-23
Next Dividend Pay Date (est.)
05-Apr-23
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
|---|---|
|
02 January 25 |
Details of Company Address
×
Details of Company Address |
|
18 December 24 |
First Half FY25 trading update
×
First Half FY25 trading update |
|
16 December 24 |
Ann Larkins appointed as Non-Executive Board Member
×
Ann Larkins appointed as Non-Executive Board Member |
|
16 December 24 |
Initial Director's Interest Notice - Larkins
×
Initial Director's Interest Notice - Larkins |
|
31 October 24 |
Chair's Address to Shareholders
×
Chair's Address to Shareholders |
|
31 October 24 |
CEO's Address to Shareholders
×
CEO's Address to Shareholders |
|
31 October 24 |
Results of Meeting
×
Results of Meeting |
|
31 October 24 |
Notification regarding unquoted securities - AHC
×
Notification regarding unquoted securities - AHC |
|
31 October 24 |
Change of Director's Interest Notice - Astles
×
Change of Director's Interest Notice - Astles |
|
30 October 24 |
Austco Healthcare Q1FY25 Trading Update
×
Austco Healthcare Q1FY25 Trading Update |
|
22 October 24 |
Change of Director's Interest Notice - Astles
×
Change of Director's Interest Notice - Astles |
|
14 October 24 |
Change in substantial shareholding from AEF
×
Change in substantial shareholding from AEF |
|
01 October 24 |
Notification regarding unquoted securities - AHC
×
Notification regarding unquoted securities - AHC |
|
01 October 24 |
Issue of Performance Rights
×
Issue of Performance Rights |
|
30 September 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
|
25 September 24 |
Change of Director's Interest Notice - Burns
×
Change of Director's Interest Notice - Burns |
|
23 September 24 |
Annual Report to shareholders
×
Annual Report to shareholders |
|
19 September 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
|
19 September 24 |
Ceasing to be a substantial holder - Correction
×
Ceasing to be a substantial holder - Correction |
|
12 September 24 |
Application for quotation of securities - AHC
×
Application for quotation of securities - AHC |
|
12 September 24 |
Change of Director's Interest Notice - Astles
×
Change of Director's Interest Notice - Astles |
|
11 September 24 |
Notification of cessation of securities - AHC
×
Notification of cessation of securities - AHC |
|
09 September 24 |
Austco expands Jurong contract to A$5.5m with phase 2 win
×
Austco expands Jurong contract to A$5.5m with phase 2 win |
|
05 September 24 |
Austco Healthcare Investor Presentation
×
Austco Healthcare Investor Presentation |
|
29 August 24 |
Appendix 4E & FY24 Financial Statements
×
Appendix 4E & FY24 Financial Statements |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
